Thompson Hine advises STERIS, and Ropes & Gray advises Becton, Dickinson and Company on the deal. STERIS plc (NYSE: STE) announced that the company has signed...
You must be a Standard 1 Year member to access this content.
Willkie Farr and Gallagher served as legal counsel to Insight Partners, while Ropes & Gray served as legal counsel to HarbourVest and Lexington. Insight Partners announced...
You must be a Standard 1 Year member to access this content.
Cleary Gottlieb Steen & Hamilton and Ropes & Gray are serving as legal advisor to Advent and Warburg Pincus, while Sullivan & Cromwell is serving as...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised H.I.G.Infrastructure on the deal. H.I.G.Infrastructure, an affiliate of H.I.G. Capital, announced the acquisition of Tower Engineering Professionals, Inc. (TEP), a leading full-service provider...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented ImmunoGen, Inc. on the deal. ImmunoGen, Inc., a leader in the field of antibody-drug conjugates, announced a global, multi-target license and option agreement...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Provention Bio, Inc. on the deal. Provention Bio, Inc., a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, announced a sales agreement...
You must be a Standard 1 Year member to access this content.
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...
You must be a Standard 1 Year member to access this content.
Cooley advised Redx Pharma on the deal while Ropes & Gray has advised Jounce Therapeutics, Inc. Redx Pharma, a UK clinical-stage biotechnology company, announced its all share...
You must be a Standard 1 Year member to access this content.
Milbank advised Werfen, while Ropes & Gray advised TPG in the transaction. TPG announced the sale of Immucor, Inc. to Werfen for approximately $2 billion, with...
You must be a Standard 1 Year member to access this content.
Freshfields advised Zymergen Inc. (Nasdaq: ZY) on the deal, while Ropes & Gray advised Ginkgo Bioworks. Zymergen Inc. (Nasdaq: ZY), a biotechnology company that uses a...
You must be a Standard 1 Year member to access this content.
Ropes & Gray and AZB & Partners advised New Mountain Capital in the deal. New Mountain Capital announced its growth partnership with Emmes, a global, tech-enabled...
You must be a Standard 1 Year member to access this content.
Ropes & Gray, working alongside Walkers, represented Pfizer, while Skadden advised Centerview Partners, the financial advisor to Biohaven Pharmaceutical on the deal. S&C, Maples and Calder...
You must be a Standard 1 Year member to access this content.
